Novavax to Present at the 14th Annual Needham Healthcare Conference
April 08 2015 - 4:02PM
GAITHERSBURG, Md., April 8, 2015 (GLOBE NEWSWIRE)
-- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
Stanley C. Erck, President and Chief Executive Officer, will
present at the 14th Annual
Needham Healthcare Conference at 8:00 a.m. ET, April 15, 2015 in
New York City at the Westin Grand Central Hotel.
A live webcast link for the presentation will be
available via the company website at www.novavax.com under Investor
Info/Events.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Its recombinant nanoparticles
and Matrix-M(TM) adjuvant technology are the foundation for
ground-breaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the company's website, www.novavax.com.
CONTACT: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#1909301
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024